Annual General Shareholders’ Meeting 2023 – June 16, 2023 - 2nd call – Expected to be held on this date / June 15, 2023 - 1st call. Click here.
Grifols is a leading global healthcare company that develops plasma-derived medicines and other innovative biopharmaceutical solutions that enable millions of patients around the world to lead more productive lives.
Since our founding in 1909, we have applied our ever-growing mastery of plasma, life sciences ethical leadership and industry-leading quality and safety standards to contribute to a healthier and more sustainable society.
Latest news
Our deep and expanding knowledge of plasma and the life sciences is helping us better understand human health and research potential treatments to improve it.
Aligned with the United Nations plan to achieve the Sustainable Development Goals defined in its 2030 Agenda, we work every day to do more and do better to contribute to the health and quality of life of people around the world.
The patients we serve are able to lead better lives. Patients inspire the work we do every day.
Our innovative medicines made from human plasma enable millions of patients with chronic and rare diseases to lead more fulfilling lives.
We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded a clinical analysis laboratory in Barcelona, the precursor to Laboratorios Grifols.
Grifols' mission, to improve people's health and well-being, has patients, donors and society at the heart of everything we do.
